SYNJ2BP is overexpressed in breast tumors compared to normal tissues (IHC score: 6–8 in 15% of tumors vs. 0–2 in normal tissues) . Key findings include:
PTEN Degradation: SYNJ2BP promotes lysosomal degradation of PTEN, activating the PI3K/AKT pathway and downstream oncogenic signaling .
EMT and Metastasis: Overexpression in MCF-7 and T47D cells reduces epithelial markers (E-cadherin, Cytokeratin 18) and increases mesenchymal markers (N-cadherin, Vimentin), enhancing migration and invasion .
In Vivo Metastasis: BALB/c mice injected with SYNJ2BP-overexpressing 4T1 cells developed larger lung metastases (p < 0.05) and accelerated weight loss compared to controls .
Mitochondrial-ER Contacts: Elevated SYNJ2BP increases mitochondrial-ER membrane contact sites in motor neurons, contributing to oxidative dysfunction in spinal and bulbar muscular atrophy (SBMA) and ALS4 .
Therapeutic Target: Reducing SYNJ2BP levels improves mitochondrial function in iPSC-derived motor neurons .
SYNJ2BP enhances lentiviral envelope protein (Env) production by regulating ER-mitochondria contact sites (MAMs), which supply ATP and Ca²⁺ required for Env synthesis .
SYNJ2BP acts as a signaling hub, interacting with :
SYNJ2: Modulates endocytosis and phosphoinositide metabolism.
ACVR2A/ACVR2B: Regulates activin receptor endocytosis via Ral/RALBP1.
LRP1/LRP2: Involved in lipoprotein metabolism.
RALA: Facilitates vesicle trafficking and cytoskeletal reorganization.
SYNJ2BP Human Recombinant is utilized for:
SYNJ2BP is a 145 amino acid protein localized to the outer mitochondrial membrane with a cytosolic PDZ domain that functions as a cellular signaling hub. The protein contains specific domains that facilitate protein-protein interactions, particularly with ER-associated proteins. Methodologically, subcellular fractionation coupled with western blotting can confirm its mitochondrial localization, while immunofluorescence microscopy using antibodies against both SYNJ2BP and mitochondrial markers (such as TOM20) provides visual confirmation of its outer mitochondrial membrane positioning . Proximity ligation assays (PLA) can further validate its interactions with specific binding partners in situ.
Based on STRING interaction network analysis, SYNJ2BP's primary binding partners include RRBP1 (Ribosome binding protein 1, score: 0.989), SYNJ2 (Synaptojanin-2, score: 0.921), ABITRAM (Protein Abitram, score: 0.826), ACVR2A (Activin receptor type-2A, score: 0.821), and RALA (Ras-related protein Ral-A, score: 0.782) . The interaction with RRBP1 is particularly important as it mediates mitochondria-ER tethering. These interactions can be studied through co-immunoprecipitation followed by mass spectrometry, which has successfully identified SYNJ2BP interactors in mitochondrial fractions . For in situ validation, proximity ligation assays can detect protein interactions occurring at distances less than 40 nm, making it ideal for confirming the spatial relationships between SYNJ2BP and its partners in intact cells .
SYNJ2BP expression increases in response to acute cellular stress. Studies in induced pluripotent stem cell (iPSC)-derived motor neurons have shown that sublethal doses of hydrogen peroxide (H₂O₂) treatment lead to elevated SYNJ2BP protein levels within two hours of exposure . This rapid upregulation suggests SYNJ2BP is part of the acute stress response pathway. Researchers can study these dynamic expression changes through time-course experiments with various stressors (oxidative stress, ER stress, hypoxia), quantifying expression changes via RT-PCR for transcript levels and western blotting for protein abundance. Transcriptional regulation can be explored through chromatin immunoprecipitation (ChIP) assays to identify transcription factors that bind to the SYNJ2BP promoter under stress conditions.
SYNJ2BP facilitates mitochondria-ER membrane contact sites (MERC) by functioning as a tethering protein between the outer mitochondrial membrane and the ER membrane. Specifically, SYNJ2BP on the mitochondrial outer membrane interacts with RRBP1 on the ER membrane to form MAM (mitochondrion-associated ER membrane) structures . This tethering mechanism has been confirmed through multiple methodologies: transmission electron microscopy (TEM) has visualized the detailed structure of MAMs in cells with altered SYNJ2BP expression, showing increased contact points between mitochondria and ER in SYNJ2BP-overexpressing cells . Additionally, proximity ligation assays (PLA) using mitochondrial (TOM20) and ER (KDEL) markers have quantitatively demonstrated that SYNJ2BP knockdown decreases mitochondria-ER proximity, while overexpression increases these contacts .
Alterations in SYNJ2BP expression significantly impact mitochondrial distribution in neurons, particularly in motor neurons. Overexpression of SYNJ2BP results in perinuclear clustering of mitochondria in the soma and reduces mitochondrial presence in axons and neurites, as demonstrated through live imaging . This redistribution effect can be quantified using the Mahalanobis distance of mitochondria in each cell, providing an unbiased measurement that does not assume a circular cell shape . SYNJ2BP knockout models show the opposite effect, with increased mitochondrial distribution throughout the cell. To study this phenomenon, researchers can employ time-lapse microscopy of fluorescently labeled mitochondria (using MitoTracker or mitochondria-targeted fluorescent proteins) combined with automated image analysis for tracking mitochondrial movement and distribution patterns.
Multiple complementary techniques can quantitatively assess mitochondria-ER contacts when studying SYNJ2BP function:
Proximity Ligation Assay (PLA): This technique can detect protein-protein interactions that occur within 40 nm, making it ideal for quantifying MERC. Using antibodies against mitochondrial markers (TOM20) and ER markers (KDEL), PLA generates fluorescent dots at sites where these organelles are in close proximity .
Confocal Microscopy with Colocalization Analysis: By labeling mitochondria and ER with different fluorescent markers, researchers can quantify overlap (yellow dots) between these organelles. The Pearson's correlation coefficient or Mander's overlap coefficient can provide numerical measures of colocalization .
Transmission Electron Microscopy (TEM): This provides the highest resolution assessment of physical contacts between mitochondria and ER, allowing measurement of the contact length and the distance between membranes .
FRET-based Biosensors: Genetically encoded fluorescent sensors placed at the mitochondria-ER interface can detect proximity changes through fluorescence resonance energy transfer.
These methods should be used in combination to provide comprehensive assessment of MERC formation in response to SYNJ2BP manipulation.
SYNJ2BP has been found to be significantly elevated in motor neurons from patients with hereditary motor neuron diseases, specifically spinal and bulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis type 4 (ALS4) . In SBMA, this elevation appears to be mediated by mutant androgen receptor (AR) toxic gain of function, as knocking out the endogenous AR reduces SYNJ2BP expression. The mechanism differs in ALS4, where SYNJ2BP protein elevation may result from altered protein turnover rather than increased gene expression. Immunohistochemical staining of patient spinal cord tissue has confirmed SYNJ2BP elevation in spinal motor neurons . This abnormal elevation contributes to disease pathology by altering mitochondrial distribution and increasing mitochondria-ER contacts, which can disrupt calcium homeostasis and energy metabolism. Research approaches should include comparative studies of SYNJ2BP expression in patient-derived samples versus controls, coupled with functional assays of mitochondrial function.
The relationship between SYNJ2BP expression and mitochondrial dysfunction appears bidirectional. Elevated SYNJ2BP expression correlates with mitochondrial stress in both SBMA and ALS4 motor neurons, characterized by impaired oxidative function . Conversely, acute mitochondrial stress (e.g., hydrogen peroxide treatment) induces SYNJ2BP expression, suggesting it may be part of a stress response pathway . The increased SYNJ2BP leads to altered mitochondrial distribution and enhanced mitochondria-ER contacts, which can disrupt calcium homeostasis and further exacerbate mitochondrial dysfunction. Significantly, reducing SYNJ2BP levels in patient-derived cells improves mitochondrial oxidative function, indicating a potential therapeutic avenue . To investigate this relationship, researchers should employ mitochondrial function assays (oxygen consumption rate, membrane potential, ATP production) in conjunction with SYNJ2BP manipulation experiments, and utilize transgenic models with controlled SYNJ2BP expression to evaluate causality.
SYNJ2BP shows promise as a therapeutic target for motor neuron diseases based on evidence that reducing SYNJ2BP levels in patient cells improves mitochondrial oxidative function . To evaluate this potential, researchers should follow a systematic approach:
Validation Studies: Confirm the effects of SYNJ2BP knockdown on mitochondrial function across multiple patient-derived cell lines and in vivo models of motor neuron disease.
Mechanism Elucidation: Determine whether benefits arise from normalized mitochondria-ER contacts, improved mitochondrial distribution, or other mechanisms.
Target Engagement Assays: Develop assays to quantify SYNJ2BP activity or its critical interactions (e.g., with RRBP1) that could serve as biomarkers.
Small Molecule Screening: Using high-throughput screening, identify compounds that modulate SYNJ2BP expression or function.
Therapeutic Window Assessment: Determine the optimal degree of SYNJ2BP reduction that improves pathology without disrupting normal cellular functions.
Delivery Method Development: For targeted therapies (such as antisense oligonucleotides or siRNAs), develop effective delivery methods to motor neurons.
Long-term Safety Evaluation: Assess potential compensatory mechanisms and long-term effects of SYNJ2BP modulation.
The most promising approach may involve partial rather than complete inhibition of SYNJ2BP function, aiming to normalize rather than eliminate mitochondria-ER contacts.
The most effective research approaches for studying SYNJ2BP in human cellular models involve a combination of genetic manipulation, imaging techniques, and functional assays:
Genetic Manipulation:
Imaging Techniques:
Confocal microscopy with co-localization analysis of mitochondria and ER
Transmission electron microscopy (TEM) for high-resolution visualization of MAM structures
Proximity ligation assay (PLA) for quantifying protein-protein interactions in situ
Live-cell imaging to track mitochondrial dynamics and distribution
Functional Assays:
Mitochondrial function assessments (oxygen consumption, membrane potential, ATP production)
Calcium imaging to assess ER-mitochondria calcium transfer
Stress response assays to evaluate how SYNJ2BP responds to various cellular stressors
Particularly powerful are patient-derived models such as induced pluripotent stem cell (iPSC)-derived motor neurons, which maintain patient-specific genetic backgrounds and have successfully been used to study SYNJ2BP in disease contexts .
For identifying SYNJ2BP interactors across cellular compartments, several complementary proteomics approaches have proven informative:
Co-Immunoprecipitation Mass Spectrometry:
Proximity-Dependent Biotinylation (BioID or APEX):
Fusion of SYNJ2BP to promiscuous biotin ligases allows labeling of proximal proteins
Different compartment-specific variants can identify interactors in distinct subcellular locations
Cross-linking Mass Spectrometry (XL-MS):
Chemical cross-linking of proteins in close proximity followed by MS analysis
Particularly useful for capturing transient interactions at membrane contact sites
Fractionation-based Approaches:
Isolation of MAM fractions compared to pure mitochondrial or ER fractions
Quantitative proteomics comparing SYNJ2BP-enriched versus depleted fractions
LOPIT (localization of organelle proteins by isotope tagging) for spatial proteomics
Targeted Approaches:
Selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) can validate and quantify specific interactions identified in discovery experiments
These methods should be combined with functional validation through imaging and biochemical assays to confirm the biological relevance of identified interactions .
Effectively manipulating SYNJ2BP expression in primary neuronal cultures requires techniques that achieve efficient gene modulation while maintaining neuronal viability:
Viral Vector Delivery:
Lentiviral or adeno-associated viral (AAV) vectors provide efficient gene delivery to primary neurons
For overexpression, vectors containing SYNJ2BP under neuron-specific promoters (e.g., synapsin) ensure targeted expression
For knockdown, vectors expressing shRNA or sgRNA (for CRISPR-Cas9) can reduce SYNJ2BP levels
Nucleofection:
Direct delivery of expression plasmids, siRNAs, or CRISPR-Cas9 components via electroporation
Should be performed prior to plating or at early stages of culture
Antisense Oligonucleotides (ASOs):
Can achieve temporary knockdown with reduced toxicity compared to viral approaches
Beneficial for temporal studies of SYNJ2BP function
Inducible Expression Systems:
Tet-On/Tet-Off systems allow temporal control of SYNJ2BP expression
Particularly useful for studying dynamic processes like stress responses
Verification Approaches:
Confirm manipulation efficiency using qPCR for transcript levels
Western blot analysis for protein levels
Immunofluorescence to assess subcellular distribution changes
When working with primary neurons, timing is critical - manipulation before key developmental stages (e.g., synaptogenesis) may yield different results than manipulation in mature neurons. Based on studies in iPSC-derived motor neurons, researchers should monitor for changes in mitochondrial distribution and function following SYNJ2BP manipulation .
SYNJ2BP regulates mitochondrial calcium homeostasis primarily through its role in maintaining and regulating mitochondria-ER membrane contact sites (MERC), which are critical calcium exchange points between these organelles. When SYNJ2BP is overexpressed, the increased formation of MERC facilitates calcium transfer from ER to mitochondria . This process affects mitochondrial metabolism, as calcium is a key regulator of mitochondrial enzymes involved in ATP production.
To experimentally measure this function, researchers can employ:
Genetically Encoded Calcium Indicators:
Targeted calcium sensors like mito-GCaMP (mitochondrial) and ER-GCaMP (ER-specific) can monitor calcium dynamics in real-time
Dual-color imaging allows simultaneous monitoring of both compartments
Calcium Flux Measurements:
Measuring calcium flux across mitochondrial membranes using calcium-sensitive dyes
Patch-clamp electrophysiology of mitochondrial calcium uniporter activity
ER-Mitochondria Calcium Transfer Assays:
Release of calcium from ER stores (using thapsigargin or IP3-generating agonists) followed by measurement of mitochondrial calcium uptake
Comparing transfer efficiency between control and SYNJ2BP-manipulated cells
Functional Consequences Assessment:
Measure mitochondrial enzyme activities affected by calcium (pyruvate dehydrogenase, α-ketoglutarate dehydrogenase)
Monitor mitochondrial ATP production in response to calcium signals
In situ Calcium Microdomains:
Super-resolution microscopy to visualize calcium microdomains at MERC
Correlation with SYNJ2BP localization
These approaches should be combined with genetic manipulation of SYNJ2BP to establish causality between SYNJ2BP levels, MERC formation, calcium transfer, and downstream functional outcomes.
The interplay between SYNJ2BP and mitochondrial protein import machinery represents an emerging area of research with important implications. As an outer mitochondrial membrane protein, SYNJ2BP persists on the OMM surface after disruption of protein synthesis and binds several mRNAs of oxidative phosphorylation (OXPHOS) proteins . This suggests SYNJ2BP may function as an RNA-binding protein (RBP) that participates in the localized translation and import of specific mitochondrial proteins.
The potential mechanisms and experimental approaches include:
mRNA Binding Analysis:
RNA immunoprecipitation (RIP) or CLIP-seq (cross-linking immunoprecipitation and sequencing) to identify SYNJ2BP-bound mRNAs
Focus on mRNAs encoding mitochondrial proteins to determine specificity
Localized Translation Studies:
Proximity-specific ribosome profiling to identify mRNAs being translated near SYNJ2BP
Visualization of translation events using puromycylation assays combined with proximity ligation
Import Assay Systems:
In vitro import assays using isolated mitochondria from cells with manipulated SYNJ2BP levels
Real-time tracking of fluorescently labeled mitochondrial precursor proteins
Interaction with Import Machinery:
Co-immunoprecipitation and mass spectrometry to identify interactions between SYNJ2BP and components of the mitochondrial import machinery (TOM/TIM complexes)
Structural studies to determine interaction domains
Functional Impact Assessment:
Measurement of import efficiency for specific mitochondrial proteins in cells with altered SYNJ2BP expression
Analysis of mitochondrial proteome composition using quantitative proteomics
While current published experiments remain limited and contain contradictions , this represents an important frontier in understanding SYNJ2BP's multifaceted roles in mitochondrial biology and potentially in age-related mitochondrial dysfunction.
SYNJ2BP-mediated mitochondria-ER contacts play critical roles in cellular stress responses through several interconnected mechanisms:
Adaptive Stress Response:
ER Stress Modulation:
ATP Availability:
Calcium Homeostasis:
SYNJ2BP-mediated MAMs facilitate calcium transfer between ER and mitochondria
This regulated calcium exchange is essential for stress signaling pathways and mitochondrial metabolic adaptation
Zinc Homeostasis:
To study these relationships, researchers should employ stress induction protocols (oxidative stress, ER stress, nutrient deprivation) combined with SYNJ2BP manipulation, while monitoring:
Unfolded protein response (UPR) markers
ATP levels in different cellular compartments
Calcium and zinc dynamics using compartment-specific sensors
Mitochondrial respiratory capacity under stress
Cell survival and recovery kinetics
The paradoxical aspect of SYNJ2BP function is that while acute upregulation appears protective, chronic elevation (as seen in neurodegenerative diseases) becomes detrimental, suggesting a time-dependent switch in its functional impact that warrants further investigation .
| Research Question | Experimental Design | Key Methods | Controls | Readouts | Advantages |
|---|---|---|---|---|---|
| Basic SYNJ2BP function | SYNJ2BP knockout and rescue | CRISPR/Cas9, rescue plasmids | WT cells, empty vector | MAM formation, mitochondrial distribution | Establishes causality |
| Role in disease | Patient-derived iPSC-motor neurons | iPSC differentiation, genetic correction | Isogenic controls | Mitochondrial function, MERC quantification | Disease-relevant model |
| Dynamic regulation | Inducible expression systems | Tet-On/Off with time-course | Uninduced cells | Temporal changes in interactome and function | Captures kinetics |
| Interactome analysis | BioID or APEX proximity labeling | Fusion proteins, MS | BirA* alone, spatial controls | Compartment-specific interactors | Identifies weak/transient interactions |
| Structure-function | Domain deletion/mutation | Site-directed mutagenesis | WT protein | Binding partner interactions, MAM formation | Maps functional domains |
| Therapeutic targeting | RNA interference screen | siRNA, shRNA libraries | Non-targeting RNA | Rescue of disease phenotypes | Identifies pathways for intervention |
| In vivo relevance | Conditional knockout mouse | Tissue-specific Cre recombinase | Floxed non-deleted | Tissue pathology, physiological function | Organismal context |
| Stress response | Controlled stress exposure | Various stressors with time-course | Unstressed cells | SYNJ2BP expression, mitochondrial function | Reveals adaptive vs. maladaptive responses |
This structured approach to experimental design provides researchers with a roadmap for investigating SYNJ2BP function across multiple contexts, from basic cellular mechanisms to disease relevance and therapeutic potential.
Several promising unexplored aspects of SYNJ2BP biology warrant further investigation:
Tissue-Specific Functions: While current research has focused on motor neurons and a few cell types, SYNJ2BP's function likely varies across tissues. Systematic comparison of SYNJ2BP's role across neural, muscle, liver, and other tissues would provide insights into tissue-specific vulnerabilities in diseases with SYNJ2BP dysregulation.
Post-Translational Modifications: The regulatory mechanisms controlling SYNJ2BP activity remain largely unexplored. Phosphorylation, ubiquitination, and other modifications likely influence SYNJ2BP's interaction with binding partners and its role in MAM formation. Phosphoproteomic approaches could identify regulatory sites and responsible kinases/phosphatases.
Temporal Dynamics: The kinetics of SYNJ2BP-mediated MAM formation and disassembly remain poorly understood. Real-time imaging of fluorescently tagged SYNJ2BP combined with optogenetic tools could reveal how these dynamics respond to cellular needs and stresses.
Signaling Integration: SYNJ2BP contains a PDZ domain that likely serves as a hub for integrating various signaling pathways. A systematic analysis of how different cellular signals converge on SYNJ2BP to regulate mitochondria-ER communication would provide valuable insights.
Role in Mitochondrial Quality Control: The potential involvement of SYNJ2BP in mitophagy, mitochondrial fission/fusion, or other quality control mechanisms remains unexplored despite its strategic location on the outer mitochondrial membrane.
Contribution to Aging: Given SYNJ2BP's relationship with mitochondrial function and stress responses, its potential role in age-related mitochondrial decline represents an important area for investigation .
Interaction with microRNAs and Long Non-coding RNAs: As SYNJ2BP appears to have RNA-binding capabilities, its potential interaction with regulatory RNAs could reveal novel mechanisms of post-transcriptional regulation.
These areas represent fertile ground for discoveries that could significantly advance our understanding of cellular homeostasis and disease pathogenesis.
Emerging technologies in imaging and proteomics offer unprecedented opportunities to deepen our understanding of SYNJ2BP function:
Super-Resolution Microscopy:
STED, STORM, or PALM microscopy can resolve MAM structures at nanometer resolution
Live-cell super-resolution imaging could capture dynamic SYNJ2BP redistribution during stress responses
Multicolor super-resolution could simultaneously track SYNJ2BP, its binding partners, and organelle markers
Cryo-Electron Tomography:
Can visualize native MAM architecture at molecular resolution
Could reveal how SYNJ2BP organizes protein complexes at the mitochondria-ER interface
Volumetric Electron Microscopy (FIB-SEM):
Provides 3D reconstruction of entire cells at nanometer resolution
Could map the complete network of SYNJ2BP-mediated contacts throughout the cell
Spatial Proteomics:
APEX-based proximity labeling combined with mass spectrometry can map the protein landscape around SYNJ2BP with nanometer precision
Multiplexed ion beam imaging (MIBI) or imaging mass cytometry could visualize protein neighborhoods in situ
Single-Cell Proteomics:
Would reveal cell-to-cell variability in SYNJ2BP expression and interactome
Could identify distinct subpopulations with different SYNJ2BP functions
Crosslinking Mass Spectrometry:
Can capture direct protein-protein interaction interfaces
Would reveal the structural basis of SYNJ2BP's interactions with partners like RRBP1
Proteome Dynamics:
Pulse-chase SILAC combined with mass spectrometry to study turnover rates
Could reveal how SYNJ2BP and interacting proteins are regulated during stress
Integrative Omics:
Combining transcriptomics, proteomics, and metabolomics data from cells with altered SYNJ2BP expression
Would provide a systems-level understanding of SYNJ2BP's impact on cellular physiology
These technologies, especially when used in combination, have the potential to resolve current contradictions in the literature and provide a comprehensive understanding of SYNJ2BP's multifaceted roles in cellular homeostasis.
Several significant contradictions and knowledge gaps exist in the current SYNJ2BP literature that warrant methodological refinement:
Contextual Function Discrepancies:
Contradiction: SYNJ2BP upregulation appears protective in some contexts (viral infection ) but detrimental in others (neurodegenerative diseases )
Resolution Approach: Systematic comparison across cell types, stress conditions, and expression levels using standardized assays for mitochondrial function and ER stress; time-course studies to distinguish acute versus chronic effects
Molecular Mechanism Inconsistencies:
Contradiction: The precise molecular interactions by which SYNJ2BP tethers mitochondria to ER remain incompletely characterized, with different studies emphasizing different binding partners
Resolution Approach: Structural biology approaches (crystallography, cryo-EM) of the SYNJ2BP-RRBP1 complex; comprehensive mutation analysis to map interaction domains; in vitro reconstitution of tethering with purified components
Physiological versus Pathological Roles:
Contradiction: The normal physiological role of SYNJ2BP versus its role in disease states is not clearly delineated
Resolution Approach: Tissue-specific conditional knockout models with careful phenotyping across multiple physiological parameters; developmental time-course studies
Transcriptional Regulation Uncertainties:
Contradiction: Different regulatory factors (AR in SBMA , stress response in other contexts) have been implicated in controlling SYNJ2BP expression
Resolution Approach: Comprehensive promoter analysis; ChIP-seq for multiple transcription factors; reporter assays with systematic mutation of regulatory elements
Mitochondrial Protein Import Role:
Therapeutic Potential Ambiguities:
Contradiction: Unclear whether SYNJ2BP inhibition or activation would be beneficial in different disease contexts
Resolution Approach: Dose-response studies with partial inhibition/activation; temporal manipulation at different disease stages; combination approaches targeting multiple aspects of MERC formation
SYNJ2BP contains a PDZ domain, which is crucial for its interaction with other proteins. This domain allows SYNJ2BP to bind to the C-terminal PDZ domain-binding motif of its interaction partners . The protein is predominantly localized in the mitochondria and the plasma membrane, where it plays a role in cellular signaling and adhesion .
SYNJ2BP has been shown to interact with the cell adhesion molecule TMIGD1. This interaction is mediated by the PDZ domain of SYNJ2BP and the C-terminal PDZ domain-binding motif of TMIGD1 . SYNJ2BP can actively recruit TMIGD1 to mitochondria, providing a potential mechanism for the localization of TMIGD1 at mitochondria .
In addition to its role in cellular adhesion, SYNJ2BP is involved in the regulation of sprouting angiogenesis, a process critical for the formation of new blood vessels . This function is particularly important in the context of cancer, where SYNJ2BP has been shown to inhibit tumor growth and metastasis by activating the DLL4-mediated Notch signaling pathway .
SYNJ2BP has been implicated in various diseases, including hepatocellular carcinoma (HCC) and Loeys-Dietz Syndrome 4 . In HCC, SYNJ2BP expression is decreased, and its low expression is associated with poor prognosis . Studies have shown that SYNJ2BP inhibits HCC cell invasion, migration, and proliferation, suggesting its potential as a therapeutic target .
The recombinant form of SYNJ2BP is used in various research applications to study its function and interactions. Understanding the role of SYNJ2BP in cellular processes and disease mechanisms can provide insights into potential therapeutic strategies for conditions such as cancer and genetic disorders.